CLARANOVA SE (CLA.PA)

FR0013426004 - Common Stock

1.91  +0 (+0.1%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to CLA. CLA was compared to 93 industry peers in the Software industry. There are concerns on the financial health of CLA while its profitability can be described as average. CLA scores decently on growth, while it is valued quite cheap. This could make an interesting combination.



4

1. Profitability

1.1 Basic Checks

CLA had negative earnings in the past year.
In the past year CLA had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: CLA reported negative net income in multiple years.
Each year in the past 5 years CLA had a positive operating cash flow.

1.2 Ratios

The Return On Assets of CLA (-1.71%) is worse than 67.47% of its industry peers.
CLA has a Return On Invested Capital of 55.60%. This is amongst the best in the industry. CLA outperforms 100.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CLA is in line with the industry average of 11.87%.
The last Return On Invested Capital (55.60%) for CLA is above the 3 year average (13.37%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -1.71%
ROE N/A
ROIC 55.6%
ROA(3y)-1.22%
ROA(5y)-5.39%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)13.37%
ROIC(5y)10.65%

1.3 Margins

Looking at the Operating Margin, with a value of 7.12%, CLA is in line with its industry, outperforming 49.40% of the companies in the same industry.
CLA's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 27.33%, CLA is not doing good in the industry: 86.75% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of CLA has remained more or less at the same level.
Industry RankSector Rank
OM 7.12%
PM (TTM) N/A
GM 27.33%
OM growth 3Y21.32%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.27%
GM growth 5Y0.82%

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CLA is creating value.
CLA has less shares outstanding than it did 1 year ago.
CLA has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CLA has a worse debt to assets ratio.

2.2 Solvency

CLA has an Altman-Z score of 0.81. This is a bad value and indicates that CLA is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of CLA (0.81) is worse than 77.11% of its industry peers.
The Debt to FCF ratio of CLA is 5.92, which is a neutral value as it means it would take CLA, 5.92 years of fcf income to pay off all of its debts.
CLA has a Debt to FCF ratio (5.92) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 5.92
Altman-Z 0.81
ROIC/WACC8.2
WACC6.78%

2.3 Liquidity

A Current Ratio of 0.58 indicates that CLA may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.58, CLA is doing worse than 95.18% of the companies in the same industry.
CLA has a Quick Ratio of 0.58. This is a bad value and indicates that CLA is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.52, CLA is not doing good in the industry: 95.18% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.58
Quick Ratio 0.52

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 73.45% over the past year.
Looking at the last year, CLA shows a decrease in Revenue. The Revenue has decreased by -2.84% in the last year.
Measured over the past years, CLA shows a very strong growth in Revenue. The Revenue has been growing by 25.71% on average per year.
EPS 1Y (TTM)73.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%134.84%
Revenue 1Y (TTM)-2.84%
Revenue growth 3Y7.41%
Revenue growth 5Y25.71%
Sales Q2Q%-4.35%

3.2 Future

Based on estimates for the next years, CLA will show a very strong growth in Earnings Per Share. The EPS will grow by 410.87% on average per year.
The Revenue is expected to grow by 3.93% on average over the next years.
EPS Next Y4483.33%
EPS Next 2Y927.41%
EPS Next 3Y410.87%
EPS Next 5YN/A
Revenue Next Year-0.29%
Revenue Next 2Y2.71%
Revenue Next 3Y3.93%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CLA. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 5.97, the valuation of CLA can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CLA indicates a rather cheap valuation: CLA is cheaper than 98.80% of the companies listed in the same industry.
CLA's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 20.65.
Industry RankSector Rank
PE N/A
Fwd PE 5.97

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CLA is valued cheaper than 93.98% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CLA is valued cheaply inside the industry as 98.80% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 4.28
EV/EBITDA 3.43

4.3 Compensation for Growth

CLA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CLA's earnings are expected to grow with 410.87% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y927.41%
EPS Next 3Y410.87%

0

5. Dividend

5.1 Amount

No dividends for CLA!.
Industry RankSector Rank
Dividend Yield N/A

CLARANOVA SE

EPA:CLA (7/12/2024, 7:00:00 PM)

1.91

+0 (+0.1%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap108.38M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 5.97
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.71%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM 7.12%
PM (TTM) N/A
GM 27.33%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.69
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.58
Quick Ratio 0.52
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)73.45%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y4483.33%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-2.84%
Revenue growth 3Y7.41%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y